Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析

◆英語タイトル:Microbix Biosystems Inc (MBX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61760FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company’s products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix provides infectious disease antigens for chlamydiaceae, STI, measles, mumps and varicella, cytomegalovirus, dengue, hepatitis, respiratory antigens, rotavirus, rubella and toxoplasma gondii. The company also provides viral and bacterial samplesfor CAP and external quality assessment (EQA) approved proficiency testing (PT) programs. Microbix is headquartered in Mississauga, Ontario, Canada.

Microbix Biosystems Inc Key Recent Developments

Mar 15,2021: Microbix & Seegene Canada form COVID-variant collaboration
Feb 16,2021: Microbix announces quality products distribution agreement
Feb 11,2021: Microbix Reports Results for Q1 Fiscal 2021
Feb 09,2021: L2 : Microbix Announces Material First Sales of Viral Transport Medium

This comprehensive SWOT profile of Microbix Biosystems Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Microbix Biosystems Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Microbix Biosystems Inc – Key Information
Microbix Biosystems Inc – Overview
Microbix Biosystems Inc – Key Employees
Microbix Biosystems Inc – Key Employee Biographies
Microbix Biosystems Inc – Key Operational Heads
Microbix Biosystems Inc – Major Products and Services
Microbix Biosystems Inc – History
Microbix Biosystems Inc – Company Statement
Microbix Biosystems Inc – Locations And Subsidiaries
Microbix Biosystems Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Microbix Biosystems Inc – Business Description
Microbix Biosystems Inc – Corporate Strategy
Microbix Biosystems Inc – SWOT Analysis
SWOT Analysis – Overview
Microbix Biosystems Inc – Strengths
Microbix Biosystems Inc – Weaknesses
Microbix Biosystems Inc – Opportunities
Microbix Biosystems Inc – Threats
Microbix Biosystems Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Microbix Biosystems Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Microbix Biosystems Inc, Key Information
Microbix Biosystems Inc, Key Ratios
Microbix Biosystems Inc, Share Data
Microbix Biosystems Inc, Major Products and Services
Microbix Biosystems Inc, History
Microbix Biosystems Inc, Key Employees
Microbix Biosystems Inc, Key Employee Biographies
Microbix Biosystems Inc, Key Operational Heads
Microbix Biosystems Inc, Other Locations
Microbix Biosystems Inc, Subsidiaries
Microbix Biosystems Inc, Key Competitors
Microbix Biosystems Inc, SWOT Analysis
Microbix Biosystems Inc, Ratios based on current share price
Microbix Biosystems Inc, Annual Ratios
Microbix Biosystems Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brigham and Women’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Brigham and Women's Hospital (BWH) is a healthcare service provider that offers patient care services. The hospital offers care coordination, ethics consultation, interpreter services, Kessler library, nutrition, patient and family relations, pharmacy, security and safety, and spiritual care …
  • GE Healthcare:企業のM&A・事業提携・投資動向
    GE Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GE Healthcare Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Continental Resources, Inc.:企業の戦略・SWOT・財務情報
    Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Finnair Oyj:企業のM&A・事業提携・投資動向
    Finnair Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finnair Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Menssana Research Inc:企業の製品パイプライン分析2018
    Summary Menssana Research Inc (Menssana) is a medical device development company that develops breath test systems. The company offers BreathLink a cloud application that concentrates, collects, and analyzes organic compounds in human breath. It also provides Breathscanner a mobile point of care sys …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tosoh Corporation:企業の戦略・SWOT・財務情報
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • LED Dental Inc:医療機器:M&Aディール及び事業提携情報
    Summary LED Dental Inc (LED Dental), a subsidiary of LED Medical Diagnostics Inc is a medical device company that offers dental products. The company develops and commercializes detection technologies utilizing tissue fluorescence visualization. Its products include dental imaging systems, CT imagin …
  • KION GROUP AG:企業の戦略・SWOT・財務情報
    KION GROUP AG - Strategy, SWOT and Corporate Finance Report Summary KION GROUP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Dawnbreaker, Inc.:企業の戦略・SWOT・財務情報
    Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Trane Technologies Plc (TT):企業の財務・戦略的SWOT分析
    Trane Technologies Plc (TT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ONGC Videsh Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary ONGC Videsh Ltd (OVL), a subsidiary of Oil and Natural Gas Corporation Limited, is an upstream oil and gas company that explores, develops and produces oil and gas from its international assets. It focuses on acquisition of exploratory and production licenses in foreign countries. The compan …
  • Hansa Medical AB (HMED):製薬・医療:M&Aディール及び事業提携情報
    Summary Hansa Medical AB (Hansa Medical) is a biopharmaceutical company that focuses on the development of novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The company's lead project, IdeS is a proprietary antibody-degrading enzyme in late stage clinical development …
  • Thomson Reuters Corporation:企業の戦略・SWOT・財務分析
    Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report Summary Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sturm, Ruger & Company, Inc.:戦略・SWOT・企業財務分析
    Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hisamitsu Pharmaceutical Co Inc (4530):企業の製品パイプライン分析
    Summary Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in …
  • Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company's service offerings include synthetic, medicinal and analytica …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆